Exiqon A/S Launches LNA™ Microrna Mimics With No Off-Target Effect
4/23/2014 9:25:59 AM
Exiqon A/S (NASDAQ OMX Copenhagen), a leading supplier of high-value gene expression analysis products, today announced the launch of highly potent miRCURY LNA™ microRNA Mimics for functional analysis.
The new miRCURY LNA™ microRNA Mimics enable sub-nanomolar potency and allow scientists to conduct high quality dose-response experiments for instance by resembling disease situations.
Help employers find you! Check out all the jobs and post your resume.
comments powered by